EPGONLINE.ORG: Keyword Density Checker

Total words: 2286 | 2-word phrases: 565 | 3-word phrases: 657 | 4-word phrases: 715

PAGE INFO

Title	Try to keep the title under 60 characters (61 characters) Personalised to Support Your Treatment Decisions \| Medthority
Description	Try to keep the meta description between 50 - 160 characters (116 characters) Medthority is an online source of credible and independent scientific content intended for healthcare professionals.
Keywords	Meta keywords are not recommended anymore (116 characters) Medthority
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	mins learning zone	26	3.96%
2	1 mins event	7	1.07%
3	mins congress highlights	6	0.91%
4	60 mins learning	5	0.76%
5	2024 1 mins	5	0.76%
6	1 mins learning	4	0.61%
7	160 mins learning	3	0.46%
8	90 mins learning	3	0.46%
9	150 mins learning	3	0.46%
10	phase iii trial	2	0.30%
11	conference 2024 1	2	0.30%
12	mins event the	2	0.30%
13	2 inflammation in	2	0.30%
14	type 2 inflammation	2	0.30%
15	zone type 2	2	0.30%
16	learning zone type	2	0.30%
17	mg 1 mins	2	0.30%
18	multiple sclerosis 115	2	0.30%
19	learning zone anticgrp	2	0.30%
20	zone hidradenitis suppurativa	2	0.30%
21	learning zone hidradenitis	2	0.30%
22	hs 30 mins	2	0.30%
23	in hs 30	2	0.30%
24	advances in hs	2	0.30%
25	zone advances in	2	0.30%
26	learning zone advances	2	0.30%
27	relapsing multiple sclerosis	2	0.30%
28	sclerosis 115 mins	2	0.30%
29	congress highlights ectrims	2	0.30%
30	adopted a positive	2	0.30%

#	Keyword	Frequency	Density
1	2024 1 mins event	5	0.70%
2	60 mins learning zone	4	0.56%
3	1 mins learning zone	4	0.56%
4	90 mins learning zone	3	0.42%
5	150 mins learning zone	3	0.42%
6	opinion recommending the granting	2	0.28%
7	relapsing multiple sclerosis 115	2	0.28%
8	multiple sclerosis 115 mins	2	0.28%
9	positive opinion recommending the	2	0.28%
10	a positive opinion recommending	2	0.28%
11	chmp adopted a positive	2	0.28%
12	use chmp adopted a	2	0.28%
13	zone advances in hs	2	0.28%
14	medicinal products for human	2	0.28%
15	for medicinal products for	2	0.28%
16	committee for medicinal products	2	0.28%
17	learning zone advances in	2	0.28%
18	the committee for medicinal	2	0.28%
19	mins learning zone advances	2	0.28%
20	in hs 30 mins	2	0.28%
21	advances in hs 30	2	0.28%
22	mins learning zone chronic	2	0.28%
23	recommending the granting of	2	0.28%
24	the granting of a	2	0.28%
25	marketing authorisation for the	2	0.28%
26	authorisation for the medicinal	2	0.28%
27	for the medicinal product	2	0.28%
28	learning zone hidradenitis suppurativa	2	0.28%
29	160 mins learning zone	2	0.28%
30	type 2 inflammation in	2	0.28%
31	zone type 2 inflammation	2	0.28%
32	learning zone type 2	2	0.28%
33	mins learning zone type	2	0.28%
34	conference 2024 1 mins	2	0.28%
35	1 mins event the	2	0.28%
36	mins congress highlights ectrims	2	0.28%
37	adopted a positive opinion	2	0.28%
38	medical education specialty drugs	2	0.28%
39	amplify phase iii trial	2	0.28%
40	education specialty drugs news	2	0.28%

#	URL	Whois	Check